Ascendis Health

ASCENDIS HEALTH SELLS BIOSCIENCES BUSINESSES FOR R480 MILLION

Johannesburg – Health and wellness group Ascendis Health is to sell the Efekto, Marltons and Afrikelp businesses within Ascendis Biosciences in a management buy-out led by RMB Ventures and Nedbank Private Equity for R480 million

May 2, 2019

Media Release 2 May 2019 The sale forms part of Ascendis Health’s divestment of non-core assets and businesses announced in September 2018. Chief executive officer Thomas Thomsen said: “Following our strategic business review last year the Biosciences division was considered as non-core to the group’s strategy and was identified for sale. While these Biosciences businesses […]

ASCENDIS HEALTH’S INTERNATIONAL GROWTH OFFSET BY WEAKER DOMESTIC PERFORMANCE

March 18, 2019

Media Release 18 March 2019 Johannesburg – South African-based international health and wellness business Ascendis Health today reported a 3% increase in revenue to R4 billion for the six months to December 2018 while normalised operating profit was 2% lower at R619 million. International revenue rose by 7% to R2 billion and accounts for 50% […]

SALE OF NON CORE ASSETS

ASCENDIS HEALTH SELLS MANUFACTURING PLANT FOR R130 MILLION

December 20, 2018

20 December 2018 Johannesburg – Ascendis Health has concluded a sale agreement of its pharmaceutical manufacturing facility in Isando, Gauteng, to Mylan, one of the world’s leading pharmaceutical companies, for R130 million. The contemplated sale forms part of Ascendis Health’s non-core asset disposal programme announced earlier this year following management’s strategic business review. Chief executive […]